Aspira Pathlab & Diagnostics Limited
BSE: ASPIRA
Prev Close
59.57
Open Price
60.01
Volume
1,621
Today Low / High
55.7 / 71.09
52 WK Low / High
50.49 / 106.78
Range
54 - 59
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 56.62, reflecting a change of -2.95 (-4.95216%). The expected target range on the BSE is 54 - 59. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Aspira Pathlab & Diagnostics Limited Graph
Aspira Pathlab & Diagnostics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aspira Pathlab & Diagnostics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 56.62, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 56.62 | 57.19 | 51.47 - 62.90 |
| 57.75 | 46.20 - 69.30 | ||
| 58.32 | 40.82 - 75.81 | ||
| Bearish Scenario | 56.62 | 56.05 | 50.45 - 61.66 |
| 55.49 | 44.39 - 66.59 | ||
| 54.92 | 38.44 - 71.40 |
Overview of Aspira Pathlab & Diagnostics Limited
ISIN
INE500C01017
Industry
Medical - Care Facilities
Vol.Avg
1,513
Market Cap
586,701,000
Last Dividend
0
Official Website
IPO Date
2024-12-30
DCF Diff
-93.97
DCF
151
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 22.00 Cr | 13.51 Cr | 8.49 Cr | 0.3858 | 0.00 Cr | 0.04 Cr | 2.03 Cr | 2.02 Cr | 1.97 | 3.52 Cr | 0.0919 |
| 2024-03-31 | 13.20 Cr | 3.39 Cr | 9.81 Cr | 0.7432 | 0.00 Cr | 1.59 Cr | -2.73 Cr | -2.67 Cr | -2.60 | -0.77 Cr | -0.2024 |
| 2023-03-31 | 14.46 Cr | 3.07 Cr | 11.39 Cr | 0.7877 | 0.00 Cr | 1.37 Cr | 0.01 Cr | -0.09 Cr | -0.09 | 1.91 Cr | -0.0061 |
| 2022-03-31 | 19.54 Cr | 4.50 Cr | 15.04 Cr | 0.7695 | 0.00 Cr | 1.05 Cr | 5.07 Cr | 4.46 Cr | 4.33 | 6.40 Cr | 0.2282 |
| 2021-03-31 | 15.21 Cr | 4.85 Cr | 10.36 Cr | 0.6812 | 0.00 Cr | 1.00 Cr | 2.07 Cr | 1.38 Cr | 1.45 | 3.61 Cr | 0.0908 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.75 Cr | 17.46 Cr | 5.30 Cr | 12.1664 Cr | 3.20 Cr | 1.05 Cr | 0.51 Cr | 3.86 Cr | 0.00 Cr | 0.00 Cr | 5.20 Cr | 2.3723 Cr |
| 2024-03-31 | 0.80 Cr | 14.71 Cr | 4.57 Cr | 10.1433 Cr | 2.78 Cr | 1.98 Cr | 0.45 Cr | 4.12 Cr | 0.00 Cr | 0.00 Cr | 2.99 Cr | 2.0710 Cr |
| 2023-03-31 | 0.57 Cr | 17.34 Cr | 4.59 Cr | 12.7504 Cr | 3.31 Cr | 1.79 Cr | 0.40 Cr | 5.31 Cr | 0.00 Cr | 0.00 Cr | 3.13 Cr | 1.5848 Cr |
| 2022-03-31 | 1.35 Cr | 18.14 Cr | 5.35 Cr | 12.7894 Cr | 3.06 Cr | 1.71 Cr | 0.40 Cr | 6.82 Cr | 0.01 Cr | 0.00 Cr | 1.08 Cr | 1.7887 Cr |
| 2021-03-31 | 1.18 Cr | 11.78 Cr | 3.46 Cr | 8.3145 Cr | 2.08 Cr | 0.13 Cr | 0.37 Cr | 4.96 Cr | 0.02 Cr | 0.00 Cr | 0.14 Cr | 2.0112 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.8271 Cr | 0.1157 Cr | -0.9942 Cr | 1.4828 Cr | 0.9486 Cr | 1.7524 Cr | -0.3443 Cr | 2.0226 Cr | -0.6468 Cr | 0.0000 Cr | -0.0641 Cr |
| 2024-03-31 | 1.0530 Cr | 0.1383 Cr | -0.9541 Cr | 0.7898 Cr | 0.2372 Cr | 0.8038 Cr | -0.2619 Cr | -2.6722 Cr | 0.1154 Cr | 0.0000 Cr | -0.0483 Cr |
| 2023-03-31 | -0.0121 Cr | 0.1593 Cr | -0.9350 Cr | -0.1484 Cr | -0.7878 Cr | 0.5666 Cr | -0.1363 Cr | -0.0887 Cr | 0.1030 Cr | 0.0000 Cr | 0.0056 Cr |
| 2022-03-31 | 2.0310 Cr | -0.5123 Cr | -1.3520 Cr | 1.4240 Cr | 0.1667 Cr | 1.3544 Cr | -0.6070 Cr | 4.4594 Cr | -0.3919 Cr | 0.0000 Cr | -0.0378 Cr |
| 2021-03-31 | 5.6734 Cr | -0.0919 Cr | -2.1720 Cr | 5.3777 Cr | 3.4094 Cr | 1.1877 Cr | -0.2957 Cr | 1.3810 Cr | -3.7849 Cr | 0.0000 Cr | -0.0902 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 5.12 Cr | 1.47 Cr | 3.65 Cr | 0.7127 | -1.59 Cr | -1.56 Cr | -1.52 | -1.08 Cr | -0.3050 |
| 2025-09-30 | 8.09 Cr | 1.62 Cr | 6.47 Cr | 0.8001 | 1.79 Cr | 1.84 Cr | 1.78 | 2.33 Cr | 0.2268 |
| 2025-06-30 | 5.25 Cr | 1.17 Cr | 4.08 Cr | 0.7770 | 0.46 Cr | 0.42 Cr | 0.41 | 0.88 Cr | 0.0803 |
| 2025-03-31 | 5.78 Cr | 3.43 Cr | 2.34 Cr | 0.4059 | 0.69 Cr | 0.68 Cr | 0.66 | 0.80 Cr | 0.1178 |
| 2024-12-31 | 5.41 Cr | 1.07 Cr | 4.33 Cr | 0.8016 | 0.38 Cr | 0.31 Cr | 0.30 | 0.79 Cr | 0.0566 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 1.49 Cr | 0.44 Cr | 1.93 Cr | 3.71 Cr | 0.66 Cr | 6.80 Cr | 3.63 Cr | 20.16 Cr | 5.74 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 2.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -12.17 Cr |
| 2025-03-31 | 2.14 Cr | 0.00 Cr | 2.14 Cr | 2.35 Cr | 0.51 Cr | 5.36 Cr | 3.86 Cr | 17.46 Cr | 5.30 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 2.41 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -11.18 Cr |
| 2024-09-30 | 2.03 Cr | 0.39 Cr | 2.42 Cr | 2.52 Cr | 0.56 Cr | 5.87 Cr | 3.49 Cr | 15.82 Cr | 4.64 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 0.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.99 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,803.00 | ₹1,121,951,678,571.00 | ₹381,240.00 |
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,043.10 | ₹1,015,033,073,603.00 | ₹2,366,853.00 |
| Fortis Healthcare Limited | FORTIS | ₹881.80 | ₹665,722,094,906.00 | ₹867,525.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,750.50 | ₹355,526,261,168.00 | ₹315,853.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹665.50 | ₹344,021,264,708.00 | ₹341,357.00 |
| Global Health Limited | MEDANTA | ₹1,105.20 | ₹297,067,116,924.00 | ₹75,686.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹688.50 | ₹275,495,656,748.00 | ₹528,722.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,183.20 | ₹120,164,798,112.00 | ₹125,027.00 |
| Jupiter Life Line Hospitals Limited | JLHL | ₹1,264.90 | ₹82,934,461,228.00 | ₹7,476.00 |
| HealthCare Global Enterprises Limited | HCG | ₹578.50 | ₹82,077,101,002.00 | ₹120,568.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹681.40 | ₹65,655,858,860.00 | ₹286,244.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹404.10 | ₹37,045,059,300.00 | ₹165,521.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹229.81 | ₹36,192,560,189.00 | ₹51,585.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Key Executives
Gender: Not Specified
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1990
Gender: female
Year Born:
Gender: Not Specified
Year Born:
FAQs about Aspira Pathlab & Diagnostics Limited
The CEO is Pankaj Jashwant Shah.
The current price is ₹57.00.
The range is ₹50.49-106.78.
The market capitalization is ₹58.67 crores.
The P/E ratio is 42.54.
The company operates in the Healthcare sector.
Overview of Aspira Pathlab & Diagnostics Limited (ISIN: INE500C01017) is a leading Medical - Care Facilities in India. With a market capitalization of ₹58.67 crores and an average daily volume of 1,513 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.